Skip to main content

Loading market data...

GEHC

GE HealthCare Technologies Inc.

NASDAQ • United states

$70.23

+$0.47

(+0.67%)

Source: Yahoo Finance · Quote time Oct 20, 2026 20:00 GMT+0000

Management
Credibility
Score

GE HealthCare Technologies Inc. (GEHC)

Unavailable

Quotes may be delayed

$31.72B

Market Cap

2,260,221

Volume

16.6

P/E Ratio

0.20%

Div Yield

GE HealthCare Technologies Inc. Price Chart

Loading price history…

Management Credibility Analysis

Unavailable

Verified Management Score Unavailable

Management credibility requires sourced guidance and earnings history.

Upcoming Catalysts

Verified event feed

Verified Catalysts Unavailable

No sourced upcoming event feed is configured for this stock yet.

Company profile

No description available

Chief executive: Not disclosed
Headquarters: 500 WEST MONROE STREET, CHICAGO, IL
Founded: Not disclosed

📈 Company Timeline

Major business events

Positive

Negative

Neutral

22 Sep 2026

GE HealthCare Technologies Inc. reported A director or senior management change or compensation event

GE HealthCare Technologies Inc. filed an 8-K covering a director or senior management change or compensation event, Regulation FD disclosure, supporting financial statements or exhibits.

18 Aug 2026

GE HealthCare Technologies Inc. reported A director or senior management change or compensation event

GE HealthCare Technologies Inc. filed an 8-K covering a director or senior management change or compensation event, supporting financial statements or exhibits.

7 Aug 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in GE HealthCare Technologies Inc..

7 Aug 2026

Large-holder ownership filing

A holder reported or amended a beneficial ownership position of more than 5% in GE HealthCare Technologies Inc..

29 Jul 2026

GE HealthCare Technologies Inc. reported Regulation FD disclosure

GE HealthCare Technologies Inc. filed an 8-K covering Regulation FD disclosure, supporting financial statements or exhibits.

Capital Structure & Financial Position

Financial strength and liquidity analysis

Cash and equivalents (USD)$2.26B

Total assets (USD)$37.13B

Total liabilities (USD)$26.23B

Shareholders' equity (USD)$10.67B

Long-term debt (USD)$10.13B

Debt due within a year (USD)$2.00M

Source: SEC EDGAR company facts (opens in a new tab) Balance sheet dated 31 Mar 2026

Peer Comparison - Health Care

Company	Price	Market Cap
LLY - Eli Lilly and Company	$1,276.13 Yahoo Finance	$1.20T
JNJ - Johnson & Johnson	$256.74 Yahoo Finance	$618.71B
ABBV - AbbVie Inc.	$284.80 Yahoo Finance	$503.28B
UNH - UnitedHealth Group Incorporated	$418.43 Yahoo Finance	$375.58B
MRK - Merck & Co., Inc.	$148.55 Yahoo Finance	$366.50B

📋 Corporate Actions

Recent and upcoming corporate events

Verified Corporate Actions Unavailable

Dividend, buyback, split, and spin-off feeds are not ingested for this stock yet.

Financials

Financial statements and key metrics analysis

Quarter	Revenue (USD)	Operating income	Net income	Diluted EPS (USD)	Filed
Q1 2026	$5.13B	$515.00M	$389.00M	$0.85	10-Q · 29 Apr 2026
Q4 2025	$5.70B	$827.00M	$589.00M	Unavailable	10-K · 4 Feb 2026
Q3 2025	$5.14B	$653.00M	$446.00M	$0.98	10-Q · 29 Oct 2025
Q2 2025	$5.01B	$654.00M	$486.00M	$1.06	10-Q · 30 Jul 2025
Q1 2025	$4.78B	$629.00M	$564.00M	$1.23	10-Q · 30 Apr 2025
Q4 2024	$5.32B	$801.00M	$721.00M	Unavailable	10-K · 13 Feb 2025

Source: SEC EDGAR company facts (opens in a new tab)

Analyst Consensus

Buy

Target: $79.81

13.6% upside potential

📈

Strong Buy

Unavailable

👍

Buy

11

⏸️

Hold

5

📉

Sell

0

16 analysts covering this stock

Source: Nasdaq analyst research (opens in a new tab) Retrieved 21 Oct 2026, 09:48 UTC Targets range 70.00–93.00 Ratings are third-party opinions, not advice.

💰 Upcoming Dividends

Next dividend payments

Verified Dividend Data Unavailable

Dividend calendar data is not ingested for this stock yet.

Guidance Evolution

Verified Guidance History Unavailable

Verified company guidance history is not ingested for this stock yet.

💼 Director Transactions

Recent insider activity

14

Sep 2026

Grogan William K

Chief Financial Officer

Grant or award

Unavailable per share

75,096 shares

3

Sep 2026

Rackliffe Philip

CEO, AIS

Tax withholding

$70.56 per share

798 shares

3

Sep 2026

O'Neill Kevin Michael

CEO, PDx

Tax withholding

$70.56 per share

718 shares

3

Sep 2026

Newcomb George A.

Chief Accounting Officer

Tax withholding

$70.56 per share

112 shares

3

Sep 2026

Kass-Hout Taha

Chief Technology Officer

Tax withholding

$70.56 per share

1,502 shares

3

Sep 2026

Jimenez Frank R

GC & Corporate Secretary

Tax withholding

$70.56 per share

1,480 shares

3

Sep 2026

Holton Adam Y

Chief People Officer

Tax withholding

$70.56 per share

673 shares

3

Sep 2026

Estrampes Catherine

Chief Commer. & Growth Officer

Tax withholding

$70.56 per share

508 shares

Top Shareholders

Vanguard Group Inc

52,275,767 shares

0.513% change

12/31/2025

Dodge & Cox

37,864,164 shares

20.925% change

6/30/2026

Blackrock, Inc.

37,467,843 shares

4.123% change

6/30/2026

Vanguard Capital Management Llc

29,724,359 shares

2.98% change

6/30/2026

State Street Corp

20,861,566 shares

1.573% change

6/30/2026

Vanguard Portfolio Management Llc

20,275,526 shares

5.694% change

6/30/2026

Invesco Ltd.

18,296,350 shares

5.738% change

6/30/2026

Harris Associates L P

15,329,664 shares

-1.701% change

6/30/2026

Barrow Hanley Mewhinney & Strauss Llc

13,455,814 shares

13.221% change

6/30/2026

Geode Capital Management, Llc

12,871,800 shares

3.808% change

6/30/2026

Source: Nasdaq institutional holdings (opens in a new tab) Observed 21 Oct 2026, 09:48 UTC· 22 hours ago

Research coverage and investment tools

GE HealthCare Technologies Inc. (GEHC) is a stock listed on the Nasdaq in the United States, in the Health Care sector (Medical Electronics). Its last price was US$70.23 on 20 Oct 2026. That is 37% of the way from its 52-week low of US$58.75 to its 52-week high of US$89.77. It paid US$0.14 a share in dividends over the last 12 months, a dividend yield of 0.20%. The latest ex-dividend date on file is 24 Jul 2026. Its market capitalisation was US$31.72 billion at that price.

Watch Add to portfolio Set an alert Compare Position size

How position sizing works Dividend yield and total return

Quarter	Revenue	Operating income	Net income	Diluted EPS	Gross margin	Operating margin	Free cash flow	Filed
Q1 2026	$5.13B	$515.00M	$389.00M	$0.85	38.5%	10.0%	—	10-Q · 29 Apr 2026 (opens in a new tab)
Q4 2025	$5.70B	$827.00M	$589.00M	Unavailable	39.7%	14.5%	—	10-K · 4 Feb 2026 (opens in a new tab)
Q3 2025	$5.14B	$653.00M	$446.00M	$0.98	38.7%	12.7%	—	10-Q · 29 Oct 2025 (opens in a new tab)
Q2 2025	$5.01B	$654.00M	$486.00M	$1.06	39.6%	13.1%	—	10-Q · 30 Jul 2025 (opens in a new tab)
Q1 2025	$4.78B	$629.00M	$564.00M	$1.23	42.1%	13.2%	—	10-Q · 30 Apr 2025 (opens in a new tab)
Q4 2024	$5.32B	$801.00M	$721.00M	Unavailable	42.8%	15.1%	—	10-K · 13 Feb 2025 (opens in a new tab)

Cash and equivalents: $2.26B
Total assets: $37.13B
Total liabilities: $26.23B
Shareholders' equity: $10.67B
Long-term debt: $10.13B
Debt due within a year: $2.00M

8-K · 22 Sep 2026 · Management change

GE HealthCare Technologies Inc. reported A director or senior management change or compensation event (opens in a new tab)

GE HealthCare Technologies Inc. filed an 8-K covering a director or senior management change or compensation event, Regulation FD disclosure, supporting financial statements or exhibits.
8-K · 18 Aug 2026 · Management change

GE HealthCare Technologies Inc. reported A director or senior management change or compensation event (opens in a new tab)

GE HealthCare Technologies Inc. filed an 8-K covering a director or senior management change or compensation event, supporting financial statements or exhibits.
SCHEDULE 13G/A · 7 Aug 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in GE HealthCare Technologies Inc..
SCHEDULE 13G/A · 7 Aug 2026

Large-holder ownership filing (opens in a new tab)

A holder reported or amended a beneficial ownership position of more than 5% in GE HealthCare Technologies Inc..
8-K · 29 Jul 2026

GE HealthCare Technologies Inc. reported Regulation FD disclosure (opens in a new tab)

GE HealthCare Technologies Inc. filed an 8-K covering Regulation FD disclosure, supporting financial statements or exhibits.

Insider	Date	Transaction	Shares	Average price	Filing
Grogan William K Chief Financial Officer	14 Sep 2026	Grant or award (A)	+75,096	—	Form 4 (opens in a new tab)
Rackliffe Philip CEO, AIS	3 Sep 2026	Tax withholding (F)	−798	$70.56	Form 4 (opens in a new tab)
O'Neill Kevin Michael CEO, PDx	3 Sep 2026	Tax withholding (F)	−718	$70.56	Form 4 (opens in a new tab)
Newcomb George A. Chief Accounting Officer	3 Sep 2026	Tax withholding (F)	−112	$70.56	Form 4 (opens in a new tab)
Kass-Hout Taha Chief Technology Officer	3 Sep 2026	Tax withholding (F)	−1,502	$70.56	Form 4 (opens in a new tab)
Jimenez Frank R GC & Corporate Secretary	3 Sep 2026	Tax withholding (F)	−1,480	$70.56	Form 4 (opens in a new tab)
Holton Adam Y Chief People Officer	3 Sep 2026	Tax withholding (F)	−673	$70.56	Form 4 (opens in a new tab)
Estrampes Catherine Chief Commer. & Growth Officer	3 Sep 2026	Tax withholding (F)	−508	$70.56	Form 4 (opens in a new tab)

Institution	Report date	Shares	Change
Vanguard Group Inc	12/31/2025	52,275,767	0.513%
Dodge & Cox	6/30/2026	37,864,164	20.925%
Blackrock, Inc.	6/30/2026	37,467,843	4.123%
Vanguard Capital Management Llc	6/30/2026	29,724,359	2.98%
State Street Corp	6/30/2026	20,861,566	1.573%
Vanguard Portfolio Management Llc	6/30/2026	20,275,526	5.694%
Invesco Ltd.	6/30/2026	18,296,350	5.738%
Harris Associates L P	6/30/2026	15,329,664	-1.701%
Barrow Hanley Mewhinney & Strauss Llc	6/30/2026	13,455,814	13.221%
Geode Capital Management, Llc	6/30/2026	12,871,800	3.808%

Previous close: 69.76 USD
Day range: 69.63 – 71.02 USD
52-week range: 58.75 – 89.77 USD
Volume: 2,260,221
Market cap: $31.72B
Average volume: 3,197,485
P/E ratio: 16.6
EPS (FY 2025, diluted): 4.55 USD
Dividends (last 12 months): 0.14 USD
Dividend yield: 0.20%
Ex-dividend date: 24 Jul 2026
Shares outstanding: 451.69M
Beta (5Y monthly): 0.72

Price, ranges and volume: Yahoo Finance (opens in a new tab) Observed 20 Oct 2026, 20:00 UTC· 1 day ago

Average volume and shares: Nasdaq (opens in a new tab) Observed 22 Oct 2026, 08:07 UTC· 36 minutes ago

Dividends: Yahoo Finance dividend history (opens in a new tab) Observed 22 Oct 2026, 08:07 UTC· 36 minutes ago

P/E is market cap ÷ trailing 12-month net income from SEC filings.

EPS: SEC EDGAR company facts (opens in a new tab)

Beta: 5 years of monthly returns against the S&P 500, calculated from Yahoo Finance prices. Market cap is the price × shares outstanding. What dividend yield leaves out: dividend yield vs total return

This research is not available for GEHC yet

Guidance history

IMPORTANT FINANCIAL DISCLAIMER: The information provided on this platform is for educational and informational purposes only and should not be construed as investment advice. All investments involve risk, including potential loss of principal. Past performance does not guarantee future results. Take Profits is not a registered investment advisor and does not provide personalized investment advice. Users should conduct their own research and consult with qualified financial professionals before making investment decisions. Market data may be delayed and is provided by third-party sources.